Cargando…

Altered signaling in anti-estrogen-resistant human breast cancer cells

Detalles Bibliográficos
Autores principales:	Lykkesfeldt, AE, Frogne, T, Jepsen, JS, Fog, CK, Larsen, SS
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233554/ http://dx.doi.org/10.1186/bcr1133

Ejemplares similares

Quantitative proteomics reveals novel proteins and central pathways associated with endocrine resistance in breast cancer
por: Løkkegaard, S, et al.
Publicado: (2011)

Activation of the Her2/neu receptor leads to antiestrogen resistance, but acquired resistance is not caused by altered ErbB expression and activation
por: Larsen, SS, et al.
Publicado: (2000)

The anti-estrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF7 breast cancer cells refractory to long-term estrogen deprivation through downregulation of ER and IGF signalling
por: Martin, L-A, et al.
Publicado: (2005)

Cyclo-oxygenase-2 expression is associated with poor clinical outcome after doxorubicin-based chemotherapy in node-positive breast cancer: integration of tissue microarray
por: Han, SH, et al.
Publicado: (2005)

Regulation of estrogen receptor beta by 5' untranslated regions in breast carcinogenesis
por: Smith, L, et al.
Publicado: (2008)

The interaction of the ER with ERBB2 and PI3K results in elevated levels of AKT and p90(RSK )in tamoxifen-resistant MCF-7 cells
por: Pancholi, S, et al.
Publicado: (2005)

Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways
por: Lundholt, BK, et al.
Publicado: (2000)

Modelling estrogen receptor alpha-positive breast cancer by transformation of normal human mammary epithelial cells
por: Schmidt, X, et al.
Publicado: (2008)

miR-18a as a potential regulator of estrogen-related genes in human breast carcinomas
por: Bueno, Renata C, et al.
Publicado: (2013)

Estrogen decreases inflammation and apoptotic signaling in the heart following severe burn injury
por: Gatson, JW, et al.
Publicado: (2010)

Polymorphisms of estrogen receptors, ERα and GPR30: association with breast cancer susceptibility and prognosis
por: Alves, Susana M, et al.
Publicado: (2010)

Simultaneous inhibition of the estrogen receptor and 6-phosphofructo-2-kinase (PFKFB3) for the treatment of ER+ breast cancer
por: Imbert-Fernandez, Yoannis, et al.
Publicado: (2014)

Immunological modulation of estrogen during sepsis
por: Stabile, AM, et al.
Publicado: (2012)

Hypoxia promotes invasion and metastasis of breast cancer cells by increasing lysyl oxidase expression
por: Erler, JT, et al.
Publicado: (2005)

Estrogen receptor 2 polymorphism in idiopathic scoliosis
por: Janusz, Piotr, et al.
Publicado: (2015)

Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors
por: Frogne, Thomas, et al.
Publicado: (2009)

Assessment of angiogenesis in the hyperplasia preinvasive, invasive breast carcinoma sequence
por: Bluff, JE, et al.
Publicado: (2008)

Coactivation of estrogen receptor alpha by the DEAD-box RNA helicases p68 and p72 and its role in breast cancer
por: Fuller-Pace, FV, et al.
Publicado: (2008)

P30. The use of HER2 receptors status as a prognostic index for estrogen receptor positive breast cancer patients
por: Tawfeek, A
Publicado: (2014)

Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells
por: Larsen, S S, et al.
Publicado: (2001)

Investigation of a new signalling pathway linking deltaD to ciliogenesis - the role of rabconnectin3
por: Tavares, B, et al.
Publicado: (2012)

Chronic critical illness: high levels of estrogens and mortality
por: Bernardeschi, G, et al.
Publicado: (2010)

Investigation of host and pathogen responses to estrogen in cystic fibrosis
por: Mulla, Moyser, et al.
Publicado: (2013)

Immortalization-associated gene signature in breast cancer
por: Dairkee, SH, et al.
Publicado: (2005)

The Cambridge breast intensity modulated radiotherapy trial
por: Coles, CE, et al.
Publicado: (2006)

Breast compression revisited
por: Poulos, AE, et al.
Publicado: (2004)

HER2 and ERβ2 downregulate estrogen-responsive element-mediated transcription activity of ERα-positive cells in response to estrogen stimulation
por: Park, B-W, et al.
Publicado: (2005)

An audit of preoperative magnetic resonance imaging staging of the breast
por: Bagnall, M, et al.
Publicado: (2006)

PLU-1/Jarid1B contributes to estrogen-induced cell proliferation in the normal mammary gland and in breast cancer, and is required for embryonic survival
por: Catchpole, S, et al.
Publicado: (2010)

Transferable resistance in multiresistant Gram-negative bacteria isolated from hemocultures in Slovakia
por: Kulkova, N, et al.
Publicado: (2015)

Functional analysis of altered Tenascin isoform expression in breast cancer
por: Alcock, RA, et al.
Publicado: (2006)

Altered myoepithelial cell expression and function in cancer-containing breasts
por: Modes, V, et al.
Publicado: (2008)

Affinity maturation pathway of an anti-MPER neutralizing mAb, CAP206-CH12
por: Tumba, NL, et al.
Publicado: (2012)

Risk factors and colonization status of methicillin-resistant Staphylococcus aureus among newly admitted newborns in neonatial intensive care unit
por: Choi, JH, et al.
Publicado: (2011)

PReS-FINAL-2026: Glucose and lipid metabolism in children with juvenile idiopathic arthritis treated with anti-TNF-alpha
por: Christensen, AE, et al.
Publicado: (2013)

The uremic retention solute p-cresyl sulfate alters NO signal transduction by alteration of the soluble guanylate cyclase redox state
por: Meijers, Björn KI, et al.
Publicado: (2009)

Influence of varying estrogen levels on trigeminal CGRP release in healthy women
por: Ibrahimi, K, et al.
Publicado: (2013)

Evaluation of the anti-angiogenic action of melatonin in breast cancer
por: Jardim, Bruna V, et al.
Publicado: (2013)

Altered radiation responses of breast cancer cells resistant to hormonal therapy
por: Luzhna, Lidiya, et al.
Publicado: (2014)

Modification of BTLA signaling motifs in TIL exhibits positive signals that mediate anti-tumor control
por: Ritthipichai, Krit, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v1fas6vssb8vqfml4jjv4r43ln